Corbus Pharmaceuticals (CRBP) announced the appointment of Rachelle Jacques as Chair of its Board of Directors, effective May 15. She succeeds Alan Holmer, who will remain on the Board.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBP:
- Corbus Pharmaceuticals price target lowered to $28 from $40 at B. Riley
- Corbus Pharmaceuticals price target lowered to $58 from $65 at RBC Capital
- Corbus Pharmaceuticals price target lowered to $56 from $60 at Oppenheimer
- Corbus Pharmaceuticals price target lowered to $40 from $50 at H.C. Wainwright
- Corbus Pharmaceuticals Advances Clinical Pipeline Amid Q1 Loss
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue